华北农学报
華北農學報
화북농학보
ACTA AGRICULTURAE BOREALI-SINICA
2014年
2期
104-109
,共6页
周晓丽%王一成%姜平%袁秀芳%李军星%杜晓莉
週曉麗%王一成%薑平%袁秀芳%李軍星%杜曉莉
주효려%왕일성%강평%원수방%리군성%두효리
大肠杆菌不耐热肠毒素B亚单位%鸭%吸收代谢%组织分布
大腸桿菌不耐熱腸毒素B亞單位%鴨%吸收代謝%組織分佈
대장간균불내열장독소B아단위%압%흡수대사%조직분포
E. coli heat-labile enterotoxin B subunit( LTB)%Duck%Dynamic%Distribution
研究重组大肠杆菌不耐热肠毒素B亚单位( rLTB)在鸭体内的吸收代谢及组织分布,为rLTB的临床应用安全性提供依据。试验鸭分别肌注1,50,100 mg/kg rLTB后,以神经节苷脂GM1酶联免疫吸附法( GM1-ELISA)测定注射后不同时间点鸭血清中的rLTB含量;连续3次肌注rLTB后,观察临床症状和剖检病理变化,并采集心脏、肝脏、脾脏、肺脏、肾脏和大脑制备组织切片,HE染色观察组织病理学变化,免疫酶组织化学染色观察rLTB在各脏器内的分布及含量变化。结果表明:鸭血清中的rLTB含量变化及维持时间与rLTB注射剂量呈正相关。1 mg/kg注射组2 h达到峰值,维持至6 h开始下降,24 h后基本检测不到;50,100 mg/kg注射组分别于2 h和1 h达到峰值,并均维持至12 h才开始下降,48 h后基本检测不到。 HE染色切片显示50 mg/kg注射组肝细胞轻度浊肿变性,肺脏轻微炎症;100 mg/kg注射组肝细胞浊肿变性明显、肺脏重度炎症、脑组织出现局灶性坏死。免疫组化染色结果显示,在被检脏器中均检出rLTB,以大脑含量最高,脾脏和肝脏次之,心脏和肺脏检出量低。 rLTB大剂量肌肉注射可引起鸭一定的组织学病变,对鸭的安全使用剂量应不超过50 mg/kg。
研究重組大腸桿菌不耐熱腸毒素B亞單位( rLTB)在鴨體內的吸收代謝及組織分佈,為rLTB的臨床應用安全性提供依據。試驗鴨分彆肌註1,50,100 mg/kg rLTB後,以神經節苷脂GM1酶聯免疫吸附法( GM1-ELISA)測定註射後不同時間點鴨血清中的rLTB含量;連續3次肌註rLTB後,觀察臨床癥狀和剖檢病理變化,併採集心髒、肝髒、脾髒、肺髒、腎髒和大腦製備組織切片,HE染色觀察組織病理學變化,免疫酶組織化學染色觀察rLTB在各髒器內的分佈及含量變化。結果錶明:鴨血清中的rLTB含量變化及維持時間與rLTB註射劑量呈正相關。1 mg/kg註射組2 h達到峰值,維持至6 h開始下降,24 h後基本檢測不到;50,100 mg/kg註射組分彆于2 h和1 h達到峰值,併均維持至12 h纔開始下降,48 h後基本檢測不到。 HE染色切片顯示50 mg/kg註射組肝細胞輕度濁腫變性,肺髒輕微炎癥;100 mg/kg註射組肝細胞濁腫變性明顯、肺髒重度炎癥、腦組織齣現跼竈性壞死。免疫組化染色結果顯示,在被檢髒器中均檢齣rLTB,以大腦含量最高,脾髒和肝髒次之,心髒和肺髒檢齣量低。 rLTB大劑量肌肉註射可引起鴨一定的組織學病變,對鴨的安全使用劑量應不超過50 mg/kg。
연구중조대장간균불내열장독소B아단위( rLTB)재압체내적흡수대사급조직분포,위rLTB적림상응용안전성제공의거。시험압분별기주1,50,100 mg/kg rLTB후,이신경절감지GM1매련면역흡부법( GM1-ELISA)측정주사후불동시간점압혈청중적rLTB함량;련속3차기주rLTB후,관찰림상증상화부검병리변화,병채집심장、간장、비장、폐장、신장화대뇌제비조직절편,HE염색관찰조직병이학변화,면역매조직화학염색관찰rLTB재각장기내적분포급함량변화。결과표명:압혈청중적rLTB함량변화급유지시간여rLTB주사제량정정상관。1 mg/kg주사조2 h체도봉치,유지지6 h개시하강,24 h후기본검측불도;50,100 mg/kg주사조분별우2 h화1 h체도봉치,병균유지지12 h재개시하강,48 h후기본검측불도。 HE염색절편현시50 mg/kg주사조간세포경도탁종변성,폐장경미염증;100 mg/kg주사조간세포탁종변성명현、폐장중도염증、뇌조직출현국조성배사。면역조화염색결과현시,재피검장기중균검출rLTB,이대뇌함량최고,비장화간장차지,심장화폐장검출량저。 rLTB대제량기육주사가인기압일정적조직학병변,대압적안전사용제량응불초과50 mg/kg。
E. coli heat-labile enterotoxin B subunit ( rLTB) exerts most effective adjuvant effects on mucosal immune responses. In order to elucidate the dynamic and the safety of rLTB for clinical use in duck,the concentra-tions of rLTB in sera,histopathological changes and tissue distribution of rLTB were examined. Ducks were bled pri-or to injection and at different time intervals post-intramuscular injection (IM) with 1,50,100 mg/kg rLTB,respec-tively. GM1-ELISA was applied for the determination of rLTB concentration in sera. The autopsy of ducks was con-ducted at different time points after IM of rLTB once a day,3 times in a row. Samples of heart,liver,spleen,lung, kidney and brain were fixed in 10% paraformaldehyde and the tissue sections were examined after coloration with haematoxylin and eosin(HE) or immunohistochemical(IHC) staining. The result showed that there was positive correlation between concentration and duration of rLTB in sera and the dosages of application. In 1 mg/kg group the amount of rLTB peaked at 2 hour post injection ( HPI) ,and started to decline at 6 HPI,and could not be detected at 24 HPI. In 50 mg/kg group and 100 mg/kg group the peak were achieved at 2 HPI and 1 HPI,respectively and began to decrease at 12 HPI,and beyond the detection limit at 48 HPI. The slight cloudy swelling and degeneration of hepa-tocellular,inflammatory cell infiltration in lung were observed in 50 mg/kg group ducks. Obvious cloudy swelling and degeneration of hepatocellular,severe inflammatory cell infiltration in lung and focal necrosis in brain tissue were ob-served in 100 mg/kg group. IHC staining results showed that rLTB was deteceted in all 6 kinds of examined organs and the highest amount rLTB was observed in brain. The conclusion is that the high dosage of rLTB may cause histo-logical lesions and the rLTB should be used under 50 mg/kg for safe in duck.